MULTIMEDIA NEWSROOM

Hosting news, sport, business, entertainment, technology, lifestyle and editorial content produced by AP Content Services and selected partners.

AP Content Services is the paid content service of The Associated Press. AP news staff were not involved in the creation of this content.
 

All video and photo content seen below is available to download without charge -  subject to agreed upon Terms and Conditions. Please ensure that you have pop-ups enabled before downloading content.

 
 
High-Level Competition at the Yacht Club de Monaco for the 42nd Primo Cup–UBS Trophy Monaco (Principality of Monaco) 6 March - The 42nd Primo Cup–UBS Trophy takes center stage in Monaco. Organised in partnership with UBS, with the support of Monaco City Hall and equipment supplier North Sails, the event has brought together over 350 sailors from different countries competing in Monaco’s waters. From J/70 to Smeralda 888, and from Longtze Premier to Cape 31, sailing itself is the true protagonist of the competition. Big names from the international sailing circuit are also present in Monaco these days, including Dawn Riley. “It’s really great to see so much activity. I’ve also been talking with the Yacht Club de Monaco about the sport of sailing. I’ve been speaking with people all over the world about how we can make the sport better", said Riley.
  • 9 March 2026

High-Level Competition at the Yacht Club de Monaco for the 42nd Primo Cup–UBS Trophy

READ MORE
  • 9 March 2026

WELEDA x Stella McCartney: Paris Fashion Week Skin Food: 100 years of loving skin

WELEDA and Stella McCartney celebrate 100 years of Skin Food at Paris Fashion Week, showcasing the iconic natural skincare backstage to prep models’ skin and highlight shared commitments to sustainability, ethics and timeless beauty. 

READ MORE
  • 9 March 2026

Menarini nears €4.9 billion in 2025 and focuses on talent and AI as ‘giant’ players enter pharma

Menarini reports strong 2025 growth to nearly €4.9 billion, highlighting investment in talent, oncology and AI-driven drug discovery while warning about rising geopolitical pressures and European regulation. 

READ MORE